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The immunoglobulin heavy-chain locus (IGH) encodes variable (IGHV), diversity (IGHD), joining (IGHJ), and constant (IGHC) genes
and is responsible for antibody heavy-chain biosynthesis, which is vital to the adaptive immune response. Programmed V-(D)-J somatic
rearrangement and the complex duplicated nature of the locus have impeded attempts to reconcile its genomic organization based on
traditional B-lymphocyte derived genetic material. As a result, sequence descriptions of germline variation within IGHV are lacking,
haplotype inference using traditional linkage disequilibrium methods has been difficult, and the human genome reference assembly
is missing several expressed IGHV genes. By using a hydatidiform mole BAC clone resource, we present the most complete haplotype
of IGHV, IGHD, and IGHJ gene regions derived from a single chromosome, representing an alternate assembly of ~1Mbp of high-quality
finished sequence. From this we add 101 kbp of previously uncharacterized sequence, including functional IGHV genes, and characterize
four large germline copy-number variants (CNVs). In addition to this germline reference, we identify and characterize eight CNV-con-
taining haplotypes from a panel of nine diploid genomes of diverse ethnic origin, discovering previously unmapped IGHV genes and an
additional 121 kbp of insertion sequence. We genotype four of these CNVs by using PCR in 425 individuals from nine human popula-
tions. We find that all four are highly polymorphic and show considerable evidence of stratification (Fst ¼ 0.3–0.5), with the greatest
differences observed between African and Asian populations. These CNVs exhibit weak linkage disequilibrium with SNPs from two
commercial arrays in most of the populations tested.Introduction
Structural variants, including deletions, insertions, and
duplications that result in changes in gene copy number
(copy-number variants, CNVs), are common features of
the human genome and are a significant source of interin-
dividual sequence variation.1–5 This form of variation has
been implicated in a broad spectrum of human pheno-
types, including adaptive traits,6 developmental and
neurological disorders,7–9 and infectious and autoimmune
diseases.10–12 Despite the impressively large number of
CNVs identified, many regions of the genome remain
poorly characterized with respect to alternate CNV-con-
taining haplotypes, as illustrated by recent resequencing
efforts that have identified a substantial portion of novel
sequence not found in the current human genome refer-
ence assembly (GRCh37).1–3,13 Particularly in regions char-
acterized by segmental duplication, missing or incomplete
sequence data hampers the ability to accurately tag such
variation by using neighboring single nucleotide polymor-
phisms (SNPs).14 As a result, genes within these complex
regions have not been fully investigated as part of routine
disease-association studies, highlighting the need for
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potential biomedical relevance.
The human immunoglobulin heavy chain (IGH) locus is
essential to the biosynthesis of functional heavy chains of
antibodies—primary components of the adaptive immune
system.15 Despite the importance of IGH, our under-
standing of locus-wide genetic variation at the nucleotide
level is largely incomplete.16 The IGH locus spans approx-
imately 1 megabase (Mb) of chromosome 14 (14q32.33)
and consists of an estimated 123–129 variable (V
[MIM147070]) genes (comprising 38–46 functional, 4–5
open reading frame [ORF], and 79–81 pseudogenes) that
are located upstream of 27 diversity (D [MIM 146910])
genes (23 functional and 4 ORF), 9 joining (J [MIM
147010]) genes (6 functional and nonfunctional genes
3 pseudogenes), and 5–11 constant (C) genes (5–9 func-
tional, 0–1 ORF, and 0–1 pseudogene)15,17–21 (IMGT Reper-
toire). Each group of IGH genes (IGHV, IGHD, IGHJ, and
IGHC) is the result of duplication and divergence, making
the IGH locus one of the most segmentally duplicated
regions of the human genome. Due to several well-charac-
terized multigene deletions in the IGHC locus, healthy
individuals can vary in IGHC copy number from 5 to 11
genes; deletions of functional IGHC genes result in theiochemistry, Simon Fraser University, Burnaby, British Columbia, V5A 1S6,
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absence of corresponding subclasses.15,17–21 These CNVs,
which were the first described in the human IGH locus,
occur within hot spots of recombination involving highly
homologous sequences.17 Allelic polymorphisms within
IGHC genes also contribute to haplotype diversity, as
demonstrated by the characterization of IGHC allotypes
and alleles.22 In the IGHV gene cluster, targeted studies
have also indicated that both allelic variation15 and
CNVs contribute to extreme haplotype diversity.23–27
Many genome-wide studies of structural variation,
however, have excluded the locus due to the difficulty of
distinguishing between structural events that occur as
the result of V-(D)-J somatic rearrangements in B-lympho-
cyte derived DNA and genuine germline variation.28
Because the majority of IGHV haplotypes harboring
CNVs have not been sequenced, the direct impacts of
haplotype diversity on IGHV gene expression and function
remain largely unexplored.
Given the role of antibodies in the immune system,
immunoglobulin loci are attractive candidates for human
disease, and several links between the IGH locus and
disease have been reported;29–33 yet, few of these associa-
tions have been replicated or fine mapped. Disease
links to IGH polymorphisms might be expected to be
common, especially for autoimmune and infectious
diseases, but whether the apparent scarcity of such associ-
ations represents a genuine absence or results from the
difficulty of effectively assaying genomic variation at
this locus remains an open question. The fact that only
a single genome-wide association study (GWAS) has
identified an association in IGH32 suggests a potential
disconnect between known IGH haplotype diversity and
current high-throughput genotyping tools. For example,
the IGHV, IGHD, and IGHJ loci have only been sequenced
and fully assembled once, and this sequence, which
stands as the current human reference assembly, is
a mosaic of large-insert clones from three libraries.20
Furthermore, this sequence is missing at least 11 func-
tional and ORF IGHV genes, and of those IGHV genes
represented, at least 16 are known or suspected to vary
in copy number.16 Thus, given both the complexity of
the locus and the lack of genomic data, it is unclear
whether GWAS and high-throughput techniques based
on next-generation sequencing fully capture genetic vari-
ation in IGH.
In order to identify and characterize additional IGH
genomic haplotypes, we undertook a project to generate
a high-quality alternate sequence assembly of the IGH
locus by using large-insert bacterial artificial chromosome
(BAC) clones from a haploid hydatidiform mole library
(CHORI-17). Hydatidiform moles result from the fertiliza-
tion of an enucleated egg followed by the doubling of
paternal germline material. The CHORI-17 hydatidiform
mole BAC library (CH17) genome is composed of only
one haplotype, and as a result, any variation observed in
assemblies can be attributed to paralogous sequence varia-
tion rather than allelic variation. This resource is, there-The Amfore, ideal for generating reliable haploid reference
sequences within complicated regions of the genome asso-
ciated with segmental duplication.34 Moreover, this tissue
has not been subjected to V-(D)-J somatic rearrangement
and thus should, in principle, harbor an unadulterated
locus representative of the germline. In this study, we
generate the most complete haploid sequence assembly
of the IGHV, IGHD, and IGHJ loci from the CH17 library
and also conduct resequencing from additional large-insert
fosmid clones from diverse ethnicities. We use these data
to map and annotate missing genes, discover large-scale
CNVs, and characterize the frequencies of a subset of these
polymorphisms in the human population. This sequence
resource provides a comprehensive set of alternate IGH
assemblies, a means to explore germline genetic variation,
and a substrate for more effective disease-association
studies.Material and Methods
Sequencing of IGHV, IGHD, and IGHJ Loci from the
CHORI-17 BAC Library
Based on BAC-end read mapping to the GRCh37 reference
genome, nine clones were selected from CH17, representing
a tiling path across IGHV, IGHD, and IGHJ gene loci, with the
exception of a 21 kbp region at the most telomeric end of
IGHV, for which no CH17 clones were identified based on anal-
ysis of BAC DNA fingerprinting and clone-end read mapping
data. All sequenced BAC clones are listed in Table S1 available on-
line. The CH17 BAC library was constructed from a complete hy-
datidiform mole at BACPAC Resources by Drs. Mikhail Nefedov &
Pieter J. de Jong by using the cell line CHM1htert created by Dr.
Urvashi Surti (BACPAC Resources Center). Clones were subjected
to traditional shotgun capillary-based dideoxy sequencing at
R8X coverage. Initial assemblies were constructed on a per clone
basis and finished to high quality (phred qualityR30); each base
was covered by at least two shotgun clones, unless finished by
PCR, and efforts to resolve issues related to repeat and segmental
duplication structure were made. All individual clone assemblies
were validated by restriction digest. IGH BAC clones were then
assembled into a larger contig spanning the length of the
IGHV, IGHD, and IGHJ loci. Contig assembly statistics are shown
in Table S2. Based on sequence quality scores, sequences gener-
ated from individual BAC clones of this haplotype are estimated
to have error rates between 1/100,000 and 1/10,000 bases. Align-
ment data from overlapping BAC clones in the tiling path suggest
that this error rate is likely to be much lower for the majority of
the locus, because we discovered 0 bp discrepancies in 279,483
junction bp from contig alignments of the six most centromeric
BAC clones in the tiling path (Table S2). We did, however,
observe minor sequence assembly discrepancies resulting from
two simple tandem repeats occurring within the overlap junction
of two BAC clones in the telomeric region of the IGHV locus
(CH17-212P11 and CH17-314I7). It is important to note that
the sequence identity within the overlap junction of these two
BAC clones outside of the simple tandem repeat sequences was
100%, and the minor discrepancies identified in this junction
did not impact analyses of CNVs or IGHV gene allelic variation
characterized from CH17.erican Journal of Human Genetics 92, 530–546, April 4, 2013 531
Mapping, Identification, and Sequencing of
Discordant Fosmids in IGH
We downloaded clone names andmapping positions for all discor-
dant fosmid clones (predicted to harbor structural variants based
on clone-end read mapping1,2) from nine human fosmid li-
braries mapping to the IGH locus (GRCh37 coordinates,
chr14:105,928,955-107,289,540) from the UCSC genome browser.
These data were based on the mapping of approximately one
million fosmid end-sequence reads per library/genome to the
GRCh37 human reference by using previously described
methods.1 Among the discordant fosmid clones, only those that
mapped to the IGHV locus were considered for sequencing. In
some cases, existing fosmids available in GenBank were also
used to directly characterize CNVs or inform additional
sequencing in particular regions to complete specific insertion
haplotypes greater than 40 kbp; in three cases, two or more over-
lapping fosmid clones were used to build contiguous assemblies in
order to fully represent CNV-containing haplotypes. Clones span-
ning one or more of any of the IGHV, IGHD, IGHJ, or IGHC gene
genomic regions were assumed to represent V-(D)-J somatic rear-
rangements, because these events are known to occur in
B lymphocyte cell lines; ten clones with one end mapping to an
IGHV gene and the other end mapping to IGHC or IGHJ were
sequenced and analyzed to validate this assumption. Selected
clones were sequenced atR8X coverage by Sanger and assembled
and finished to high quality by using methods described above for
CH17 BAC clones when possible. Completed assemblies were
submitted to GenBank (Table S1).Identification of Genes and Regulatory Regions from
Sanger-Sequenced BAC and Fosmid Clones
For IGHV gene identification and positioning, we analyzed
complete sequences from each of the 9 BAC and 55 fosmid clones
individually. Sequences of all functional and ORF IGHV, IGHD,
and IGHJ genes were downloaded from IMGT/GENE-DB (GENE-
DB35 at IMGT, the international ImMunoGeneTics information
system,36–39 and IMGTAlignments of alleles) and aligned to BAC
and fosmid sequences using BLAST.40 Once positioned, sequences
at each gene locus were extracted, and alleles were determined
using IMGT/V-QUEST.41,42 For the identification of regulatory
elements, we extracted sequences of IGHV genes and flanking
regions identified in the CH17 haplotype, as well as those IGHV
genes identified in completed fosmids for which regulatory
elements had not been previously characterized; these sequences
were aligned with homologous IGHV gene sequences from
GRCh37 and visually scanned for previously identified motifs.20Analyses of IGHV Gene Copy Number Variation
Identified in BAC and Fosmid Clones
Based on methods described previously,2,43 clones were compared
to the human genome reference assembly using the programMir-
opeats.44 The breakpoints of identified variants were analyzed by
aligning extracted sequences that spanned the predicted variant-
associated breakpoints fromGRCh37 and the BAC or fosmid clone
sequences being compared. To identify any putative repeat
sequences flanking or spanning CNV breakpoints, intrasequence
alignments of sequence generated from the haplotype in which
the event was suspected to have occurred were carried out using
BLAST.45 Alignments of identified repeats were then generated
by using Needle46 to calculate pairwise sequence similarities. Mul-
tisequence alignments of event-associated repeats spanning the532 The American Journal of Human Genetics 92, 530–546, April 4, 2breakpoints from GRCh37 and variant haplotypes were generated
using Clustal W47 and visualized in SeqMan Pro (DNASTAR Laser-
gene, Madison, WI, USA), in most cases allowing for the determi-
nation of the region in which crossovers associatedwith each CNV
occurred.
Given the identification of several diverse CNVs located
between IGHV4-28 to IGHV4-34, putative variant breakpoints in
this region were characterized by constructing a large multise-
quence alignment containing all portions of the event-mediating
~25 kbp segmental duplication blocks annotated from every BAC
and fosmid clone spanning the region (Figure S1). Stretches of
sequence between segmental duplications exhibiting the highest
sequence similarity were then identified to determine the most
likely segmental duplications mediating each event, generally al-
lowing for the delineation of regions harboring event breakpoints.
Gene synteny based on allelic descriptions at genes in these haplo-
types was also considered.PCR Genotyping of CNVs in 1000 Genomes Project
Population Samples
PCR assays were designed for four of the CNVs identified from the
fosmid and BAC clones. Where possible, primers were designed to
generate products spanning identified variant breakpoints to
allow for allele-specific amplification of either the reference or
BAC/fosmid alleles. For the insertion containing IGHV1-69D,
IGHV2-70D, IGHV1-f, and IGHV3-h genes, TaqMan copy number
assay primers and probes were designed per manufacturer instruc-
tions by using primer express software (ABI). Additional primers
targeting unique sequence near IGHV1-f were also designed to
test for the presence of this haplotype by using standard PCR.
PCR primers and probes are listed in Table S3. PCR primers were
first validated by using BAC or fosmid clone DNA from which
the variants were identified, as well as a selected panel of individ-
uals from the 1000 Genomes (1KG) Project, including those indi-
viduals used to construct fosmid libraries analyzed in this study.
Validated PCR assays were subsequently genotyped in a total of
425 unrelated 1KG individuals from each of 9 geographic popula-
tions: Han Chinese (CHB, n ¼ 45), Japanese (JPT, n ¼ 46), Finnish
(FIN, n ¼ 48), British (GBR, n ¼ 48), Iberian (IBS, n ¼ 48), Toscani
(TSI, n¼ 48), Yoruba (YRI, n¼ 48), Luhya (LWK, n¼ 48), andMaa-
sai (MKK, n ¼ 46) (Table S4). The use of human subjects was
approved by the Human Subjects Review Committees of the
University of Washington. In addition, PCR assays were used to
screen DNA from four nonhuman primate species (Pan troglodytes,
n ¼ 5; Gorilla gorilla, n ¼ 5; Pongo pygmaeus, n ¼ 2; Pongo abelii,
n ¼ 3). Products of CNV breakpoint allele-specific PCR amplifica-
tions were visualized on agarose gels for genotyping; PCR products
produced from nonhuman primates were sequenced and aligned
to characterized CNV-containing BAC or fosmid clones to confirm
the presence of the correct amplification products. Copy-number
estimates for each individual, using the IGHV1-69 and IGHV2-70
duplication assay, were analyzed using DDCt. TaqMan copy
number assay estimates were used to infer the frequency of the
one-copy or two-copy genotypes, and these were compared to
the IGHV1-f insertion assay results. PLINK was used to assess allele
frequencies for genotyped polymorphisms,45 and pairwise Fst was
used to assess population differentiation for each of the genotyped
loci. Genotypes for SNPs found on the Affy6.0 and Illumina Omni
1 Quad arrays were downloaded from the 1KG data sets48 for the
319 individuals that overlapped with those genotyped above
(Table S4). Linkage disequilibrium (LD) estimates between alleles013
at these SNPs and alleles at each of the structurally variant loci gen-
otyped above were assessed using r2 in PLINK,45 considering all
SNP genotypes within the IGH locus (GRCh37 coordinates,
chr14:105,928,955–107,289,540).Results
Sequencing and Assembly of the IGHV, IGHD, and
IGHJ Loci from the CH17 BAC Library
We sequenced a complete haplotype of the IGHV, IGHD,
and IGHJ loci (14q32.33) by selecting CH17 hydatidiform
mole BAC clones whose end-sequences specifically map-
ped to the IGH locus. High-quality capillary-based Sanger
shotgun sequence was obtained for each of the IGH BAC
clones, and overlapping clones were aligned to create
a contiguous assembly encompassing the IGHV, IGHD,
and IGHJ genes. The resulting IGH haplotype consists of
1,073 kbp of sequence spanning IGHJ6 to 49 kbp upstream
of IGHV3-74. The most telomeric 50 end of the locus
(~21 kbp based on GRCh37), including the previously
described IGHV gene, IGHV7-81, and four IGHV pseudo-
genes,20 was not included in the CH17 assembly, as no
BAC clones were identified from the library in this region.
Despite this small gap, the CH17 IGH haplotype represents
the most complete sequence spanning the IGHV, IGHD,
and IGHJ loci generated from a single chromosome. Acces-
sion numbers and sequences for CH17 BAC clones
analyzed in this study have been deposited in GenBank
(Table S1), and the AGP tiling path for our assembly is
described in Table S2.Identification of IGHV, IGHD, and IGHJ Genes and
Alleles from the CH17 Sanger Assembly
Based onmapping of known IGH genes available in IMGT/
GENE-DB35 and IMGT Alignments of alleles at
IMGT,36–39 the CH17 haplotype includes 47 IGHV genes
(44 functional and 3 ORF), 27 IGHD genes (23 functional
and four ORF), and 6 functional IGHJ genes. Alleles at
these loci were annotated by comparing their sequences
to IMGT (Figure 1, Table S5). Previously uncharacterized
alleles were identified in the CH17 haplotype for five
single-copy IGHV genes (IGHV4-28*07, IGHV3-20*02,
IGHV1-18*04, IGHV3-13*05, and IGHV3-11*06); in addi-
tion, we described an allele at the duplicated gene
IGHV3-64D*06. These alleles were approved by the
WHO/IUIS/IMGT Nomenclature Committee.49,50 In each
case, allelic variants were represented as SNPs in dbSNP135
and in the 1KG data sets48 (Table S5). The remaining IGHV
alleles from the CH17 haplotype were listed in IMGT
Alignments of alleles51 and in IMGT/GENE-DB,35 as were
all alleles at IGHD and IGHJ gene loci.
A direct comparison of this CH17 assembly to that of the
human genome reference revealed the presence of four
large CNVs involving ten functional IGHV genes,
including two insertions and two complex insertion/dele-
tion events (Figure 1; Table 1; Figure S2). We refer toThe Amcomplex events as those for which a haplotype harboring
a CNV requires more than two breakpoints to reconcile
the variant with the human reference genome and is there-
fore not a simple insertion, deletion, or inversion (e.g., the
IGHV5-a and IGHV3-64D haplotype versus the IGHV3-9
and IGHV1-8 haplotype). Importantly, a complex event
can be best described in the context of a haplotype other
than the human reference sequence; for example,
although the complex event in CH17 involving IGHV4-
30-2 is significantly different from GRCh37 with respect
to nucleotide similarity, based on sequence analysis
(Figures S1 and S8) this event was most likely mediated
by an alternate insertion haplotype described from fosmid
clones in this study (see below).
We determine that the CH17 haplotype harbors
101 kbp of sequence not represented in GRCh37. With
respect to gene copy number differences, the CH17 IGHV
haplotype differs from GRCh37 by four CNVs that involve
ten IGHV genes (seven gains and three losses; Figure 1;
Figures S2 and S3A). Of the 47 IGHV genes identified in
the CH17 haplotype and the 43 identified in the human
genome reference assembly (excluding IGHV7-81), 40
were shared (Figure S3B). Allelic differences were observed
at 18 of these 40 IGHV genes, 14 of which involved amino
acid changes between the two haplotypes (Figure 1; Table
S5). In contrast to the IGHV locus, we did not observe
any allelic differences at IGHD and IGHJ loci between
the CH17 haplotype and GRCh37 (Table S5).
We also annotated 50 and 30 regulatory regions of the
IGHV genes in CH17, including the 30 recombination
signal (RS) sequences, which are necessary for proper
somatic rearrangement of IGHV genes to partially rear-
ranged IGHD-J15 (Table S6). For genes that occur in identi-
fied CNVs, we provided a complete description of their
regulatory regions (e.g., IGHV7-4-1). Regulatory sequence
motifs for all CH17 haplotype IGHV genes were also
compared to those reported in Matsuda et al.20 No varia-
tion was observed in the characterized regulatory
sequences for IGHV genes shared between the CH17
haplotype and the GRCh37 assembly, even for genes at
which we identified different alleles. However, for the
IGHV3-64D duplicate gene that occurred as part of
a complex event in CH17 (Figure 1), the RS nonamer
differed from that described for IGHV3-64*0220 by two
nucleotides (Table S6). This sequence matched with
100% identity to RS nonamers from other IGHV genes.
Discovery and Sequence Characterization of
Additional CNV Haplotypes in IGHV
We further explored CNVs in the IGHV locus by complete
sequencing of large-insert fosmid clones mapping to the
region. The clones were part of a fosmid end-sequence
mapping project previously developed to characterize
structural variation in the human genome.1–3 The primary
libraries used here were constructed from nine individuals
(two YRI, two JPT, two CHB, two individuals of European
descent (CEPH), and one individual of unknownerican Journal of Human Genetics 92, 530–546, April 4, 2013 533
Figure 1. Schematic Comparisons of IGHV Haplotype between CH17 and the Human Reference Genome Assembly (GRCh37)
(A) Functional andORF IGHV genes annotated from each reference are depicted by filled boxes with corresponding IGHV gene locus and
allele identifiers located above and below the haplotypes.
(B) The positions of two insertions and two complex events characterized from the CH17 haplotype are shown mapped to the GRCh37
IGH human reference assembly sequence (black line; chr14:105,928,955-107,289,540). The locus is presented in the same orientation as
that depicted by IMGT. Functional and ORF IGHV, IGHD, and IGHJ genes (not to scale) and IGHV pseudogenes are shown (to scale); the
names of IGHV genes involved in the characterized structural variants are indicated. Segmental duplications82,83 downloaded from the
UCSC genome browser are shown below GRCh37.ethnicity). We identified a total of 191 discordant clones
mapping to the IGH region from the nine libraries (47
insertion and 144 deletion clones). Of the 144 clones sus-
pected to harbor deletions, 86 spanned IGHV, IGHD,
IGHJ, and/or IGHC gene loci, based on end-read mapping
positions, and were presumed to represent somatic V-(D)-J
rearrangements. These are expected because the DNA used
for fosmid library construction was isolated from Epstein-
Barr virus (EBV) transformed B cell lines that undergo
somatic rearrangements at immunoglobulin loci. To vali-
date this assumption, we sequenced ten fosmid clones
with suspected somatic rearrangements (Table S8)—an
example of one of these fosmids in comparison to
GRCh37 is shown in Figure S5. In addition, 23 deletion
clones and 3 insertion clones mapped within the IGHC
gene locus only and were excluded from further analysis;
however, it is worth noting that IGHC-containing CNVs
have been described previously.17–19,21,22,52,53 In addition534 The American Journal of Human Genetics 92, 530–546, April 4, 2to this set of clones, fully sequenced fosmids from
a previous genome-wide data set/analysis43 based on
a second set of libraries (eight individuals, from the same
ethnicities) were also searched for possible CNV-contain-
ing clones in IGHV.
In total, we analyzed complete inserts of 17 discordant
fosmid clones mapping to the IGHV locus, characterizing
8 CNV haplotypes (Table 1; Figure 2; Figure S4; an addi-
tional nine fosmids were also analyzed and found to
contain either partial or no structural variation, Table S1).
The corresponding CNVs from the aforementioned 17
clones involve copy number changes in 13 functional
and ORF genes (not including those that overlapped with
CH17), two of which (IGHV3-43D and IGHV3-38) had
not been associated with CNVs prior to this study. In addi-
tion to that characterized above in CH17, we generated an
additional 121 kbp of insertion sequence not present in
GRCh37. We identified ten previously uncharacterized013
Table 1. CNVs Identified from BAC and Fosmid Clones
Individual Population CNV Type
IGHV Genes
Included in CNVa
GRCh37
Outer-Start
(Breakpoint)b
GRCh37
Outer-End
(Breakpoint)b
Event Size
(~kbp) Accessions/Clones
CH17 nd Insertion V1-69D, V1-f, V3-h,
V2-70D (gain)
107174927 107174941 46.6 AC245023, AC245094
CH17 nd Complex event V4-30-2 (gain) V4-31
(loss)
106804332 106810878 6.5c/48.8d AC245166
CH17 nd Complex event V5-a, V3-64D (gain)
V3-9, V1-8 (loss)
106531320 106569343 38c/37.7e AC245085, AC247036
CH17 nd Insertion V7-4-1 (gain) 106483362 106484225 9.5 AC244226, AC245085,
AC247036
NA12156 CEPH Deletion V4-39, V3-38 (loss) 106866357 106899042 32.7 AC244497
NA15510 and
NA19240
nd and Yoruba Insertion V1-c, V3-d, V3-43D,
V4-b (gain)
106877146 106877535 61.1 AC241995, AC234225;
AC233755, KC162926f
NA18555
(haplotype A)
Han Chinese Complex event V3-30-5, V4-30-4,
V3-30-3, V4-30-2 (gain)
106804332 106804333 49.2 KC162924, AC231260,
AC244456, KC162925
NA18555
(haplotype B)
Han Chinese Deletion V4-31, V3-30 (loss) 106786254 106811213 24.9c/73.9d AC244464
NA18507 Yoruban Complex eventg V4-30-4, V3-30-3 (gain)
V3-30 (loss)
106784242 nd 25.2 AC244411
NA18502 Yoruban Complex eventg V3-30-5 (gain) V3-33,
V4-31 (loss)
nd 106820685 24.7 AC245243
NA18956 and
NA12156
Japanese and
CEPH
Duplication V3-23D (gain) 106716650 106727861 10.8 AC244473, AC206018;
AC244492
NA19240 and
NA12878
Yoruban and
CEPH
Insertion V7-4-1 (gain) 106483362 106484225 9.5 AC241513; AC245090
nd, not defined;
aGenes either lost or gained in the context of GRCh37 as part of CNV-containing haplotypes are noted.
bCoordinates delineate regions in which event breakpoints are predicted to have occurred.
cEvent size with respect to GRCh37.
dEvent size with respect to NA18555 haplotype A (see Figure 4).
eEvent size with respect to CH17.
fClones from these two individuals were used to build a composite haplotype.
gPartially characterized.IGHV alleles from functional and ORF genes identified in
the fosmid sequences (Table S7). In all cases for which
alleles were described at IGHV genes present in GRCh37,
variants were represented by SNPs in dbSNP135 and/or
1KG data sets. In addition, we characterized 50 regulatory
regions and 30 RS sequences for IGHV genes identified in
the fosmid data that previously lacked complete descrip-
tions of these elements;39 in all cases, sequences matched
those of other IGHV genes (Table S6).
Analysis of CNV Breakpoints and Inference of
Mutational Mechanisms
By using previously described methods,43 we assessed the
breakpoints of the CNVs described here, as well as previ-
ously identified breakpoints of the IGHV4-61 deletion5
(Tables 1 and 2; Figures 1 and 2; Figures S6–S14). Despite
being able to determine event breakpoints, we were not
able to infer the mutational mechanism underlying the
complex CNV involving the genes IGHV1-8, IGHV3-9,
IGHV5-a, and IGHV3-64D because this variant was not
consistent with mechanisms typically associated withThe Amsimple insertion, deletion, or duplication events
(Figure S6). For all other events, we searched for and iden-
tified stretches of extended sequence homology flanking
or spanning the breakpoints—a characteristic feature of
nonallelic homologous recombination (NAHR).43 An
example is shown in Figure 3 for the duplication event
involving IGHV3-23 [MIM 611939], one of the most
highly expressed genes in naive antibody repertoires.29,54
We identified two 5.3 kbp repeat segments (86% similarity)
in GRCh37, suggesting that this duplication likely arose
as a result of NAHR.
The lengths of repeat segments (extended homology)
involved in each of the analyzed CNVs varied, ranging
from 600 bp to 38 kbp in size (Table 2). Sequence identities
between repeat segments also varied, but in most cases
where crossover events were suspected to have occurred,
we observed shorter stretches of sequence with almost
perfect sequence identity (>98%) within the predicted
breakpoint regions (e.g., Figure 3C). However, in several
instances, likely due to the accumulation of mutations
(some of which might be population-specific) followingerican Journal of Human Genetics 92, 530–546, April 4, 2013 535
Figure 2. Map of IGHV CNVs Identified by Complete Sequencing of Fosmid Clones
The positions of three deletions, two insertions, one duplication, and one complex event characterized from fosmid alternative haplo-
types are shown mapped to the GRCh37 IGH reference (black line; chr14:105,928,955–107,289,540) with the same parameters as in
Figure 1B. The locus is presented in the same orientation as that depicted by IMGT. Functional and ORF IGHV, IGHD, and IGHJ genes
(not to scale) as well as IGHV pseudogenes are shown (to scale); the names of IGHV genes involved in the characterized structural vari-
ants are indicated. Segmental duplications82,83 downloaded from the UCSC genome browser are shown below GRCh37. The large red
box indicates a hotspot region of recurrentmutation (see Figure 4 for additional haplotypes associatedwith this hotspot). The deletion of
IGHV4-61 was identified by Mills et al.5 (chr14:107,084,861–107,096,738) and was also included in our analyses.the formation of the CNV, we were not able to predict
with certainty where the breakpoints occurred based on
the sequences available (e.g., Figures S10 and S14; Table
2). With the exception of the IGHV7-4-1 insertion, all
predicted event-mediating (referred to as extended
homology) repeats contained IGHV genes or pseudogenes
(Table 2). Notably, within the region spanning IGHV4-28
to IGHV4-34, which has previously been shown to exhibit
extreme haplotype variation24,25,55,56 and has been impli-
cated in several autoimmune disorders,24,31,33,57,58 we
identified evidence of an NAHR hotspot. Five distinct
CNVs were characterized, all of which were predicted to
be mediated by crossover events involving large ~25 kbp
segmental duplications (Figure 4). Each of these duplicated
blocks includes two functional IGHV genes. Compared to
GRCh37, which contains two ~25 kbp segmental dupli-
cates, one of the haplotypes identified in NA18555 in
this region contained two additional repeated ~25 kbp
segmental duplications (Figure 4). The exact mechanisms
mediating this expanded haplotype could not be deter-
mined (Figure S1); however, based on sequence similarity,
it was clear that several events were mediated by segmental
duplication blocks found in this haplotype, rather than by
those represented in GRCh37 (Figure 4; Figures S1 and
S12–S14). The haplotypes identified here in this region
are corroborated by previous data,27 but this represents
a comprehensive description of these variants at nucleo-
tide resolution.536 The American Journal of Human Genetics 92, 530–546, April 4, 2It is also important to note that although the sequence
identity between characterized allelic 25 kbp segments in
this region was higher than that observed between paralo-
gous segments, point mutations were also observed
between homologous segments from different haplotypes.
Thus, further sequencing of this region inmore individuals
will be required to fully catalog the range of nucleotide
variation between homologous and paralogous segmental
duplicates, which will be essential for the development of
effective genotyping tools and more precise delineation of
event breakpoints. Additional resequencing is likely to
yield the discovery of novel structurally variant haplo-
types, which might shed more light on the history of
these events. For example, the gene IGHV4-30-1 is also
known to be present in this region24,25,55,56 but was not
identified as part of the CNVs characterized here.
Population Stratification of IGHV CNVs
To assess the global frequency of a subset of the discovered
IGHV CNVs, we genotyped 4 of these in a total of 425
individuals from 9 diverse populations. For three of
the CNVs (the IGHV1-c, IGHV3-d, IGHV3-43D, and
IGHV4-b insertion; the IGHV3-64D, IGHV5-a, IGHV3-9,
and IGHV1-8 complex event; and the IGHV7-4-1 inser-
tion), we designed haplotype-specific primers for standard
PCR. For the fourth CNV corresponding to the IGHV1-
69D, IGHV1-f, IGHV3-h, and IGHV2-70D insertion, we
used a TaqMan Copy Number Assay, in addition to013
Table 2. Analysis of CNV Breakpoints
CNV Type IGHV Genes in Event
Shared Sequence
at Breakpointa (bp)
Extended
Homology (~kbp)
Sequence
Identityb
IGHV Genes in Regions
of Extended Homology
Insertion V1-69D, V1-f, V3-h,
V2-70D
13 38 0.94 V2-70, V1-69D, V2-70D, V1-69
Deletionc V4-61 58 5.6 0.95 V3-62P, V3-60P
Insertion V1-c, V3-d, V3-43D,
V4b
nd 11.7 0.93 V4-39, V4-b
Deletion V4-39, V4-38 24 0.73 0.79 V3-41P, V3-38
Complex event V4-31, V3-30-5,
V4-30-4, V3-30-3d
47 25 0.92 V3-30-3, V4-30-2, V3-30, V4-28
Complex event
(NA18555 haplotype A)
V3-30-5, V4-30-4,
V3-30-3, V4-30-2
nde 25 0.94 V3-33, V4-31, V3-30-5, V4-30-4
Deletion
(NA18555 haplotype B)
V4-31, V3-30 249 25 0.94 V3-33, V4-31, V3-30, V4-28
Complex event V3-30, V4-30-2c 61 25 0.94 V3-33, V4-31, V3-30, V4-28
Complex event V3-33, V4-31c nd 25 0.92 V3-33, V4-31, V3-30-3, V4-30-2
Duplication V3-23D 373 5.3 0.86 V3-23, V3-22P
Insertion V7-4-1 nd 0.86 0.97f No IGHV genes
nd, not determined.
aLength of shared sequence at predicted breakpoint with greater than 98% sequence identity.
bPercent sequence identity between regions of extended homology spanning event breakpoints.
cDeletion identified by Mills et al.5 (chr14: 107,084,861–107,096,738).
dGenes that are deleted in the context of haplotype A (see Figure 4)—genes listed for other events (insertion/deletions, duplications) represent changes in the
context of GRCh37.
eAlthough this haplotype could be defined as an insertion based on a direct comparison to GRCh37 and CH17, due to the complicated duplication structure in the
region, the exact mechanisms underlying this event could not be determined based on available haplotypes (see Figure S1A).
fCalculated from CH17 haplotype.haplotype-specific standard PCR assays designed near
IGHV1-f. The allele frequencies for each event are listed
in Table 3. We examined population stratification by using
Fst. In contrast to genome-wide average pairwise Fst values
for common autosomal SNPs, which are typically less than
0.2,59 all four CNVs showed significant population stratifi-
cation, with population pairwise Fst values reaching 0.5 for
some variants (Figure 5). For example, the ~61 kbp inser-
tion containing IGHV1-c, IGHV3-d, IGHV3-43D, and
IGHV4-b was highly stratified between African and Asian/
European populations (Figure 5A). Additionally, copy
number of the IGHV1-69 and IGHV2-70 haplotype was
also highly stratified between the three major continental
groups, with Asians having fewer copies than Africans
(Figure 5B; Table 3). We observed that all individuals
with more than three copies of IGHV2-70 and IGHV1-69
in their genome also carry IGHV1-f; however, this gene
was observed in several individuals for which only two
IGHV1-69/IGHV2-70 copies were predicted, suggesting
that some variability in our custom TaqMan assay exists,
which has likely resulted in an underestimation of copy
number in some individuals.
We also genotyped these four CNVs in five chimpanzees
(Pan troglodytes), five gorillas (Gorilla gorilla), and five
orangutans (two Bornean, Pongo pygmaeus, and three Su-
matran, Pongo abelii) (Table 3). Strikingly, the presence of
each CNV was noted in at least one nonhuman primate,The Amsuggesting that none of these variants are unique to hu-
mans. Interestingly, the IGHV5-a and IGHV3-64D haplo-
type was observed in orangutan in the absence of
IGHV3-9 and IGHV1-8, whereas the converse was noted
in chimpanzee and gorilla. Likewise, the haplotype con-
taining the insertion of IGHV1-69D, IGHV1f, IGHV3-h,
and IGHV2-70D was amplified in gorilla, indicating that
a duplication of IGHV1-69 and IGHV2-70 could have
preceded the split of gorillas from the chimpanzee/human
lineage. The fact that this variant was not detected in
chimpanzees or orangutans could indicate an actual
difference between species or simply reflect effects of
potential species-specific variants on assay performance
or the limited number of individuals screened. Further
to this point, in a number of instances we found that
CNV allele frequency was less than 1.0 (Table 3); however,
these are the result of a lack of PCR product generated
from some individuals for assays of both alleles at a given
CNV locus (e.g., IGHV7-4-1 insertion in chimpanzee).
Thus, the extent to which the loci screened here are
polymorphic and stratified within nonhuman primate
species will require additional genotyping in a larger panel
of samples.
To investigate whether IGHV CNVs were in LD with
SNPs found on commercial arrays, we downloaded geno-
types for Affymetrix 6.0 and the Illumina Omni 1 Quad
array SNPs in individuals from 1KG data sets for seven oferican Journal of Human Genetics 92, 530–546, April 4, 2013 537
Figure 3. Breakpoint Analysis of the IGHV3-23 Duplication
(A) Pairwise BLAST alignment of 38 kbp region surrounding IGHV3-23 in GRCh37 (chr14:106700594–106738594). Brown and orange
dotted arrows point to ~5.3 kbp repeat sequences (extended homology) suspected to have mediated the IGHV3-23 duplication. Repeat
sequences show 86% sequence identity.
(B) Sequence harboring the IGHV3-23 duplication identified in individual NA18956 (clones AC244473 and AC206018) is compared to
GRCh37 (chr14:106700594–106738594). Regions of similarity between the two haplotypes are connected by black lines. Segments
colored in blue in both haplotypes indicate the locations of the 10.8 kbp duplicates. Brown and orange bars above the NA18956 haplo-
type and below the GRCh37 haplotype indicate ~5.3 kbp repeat sequences identified by BLAST in (A). Labeled IGHV genes and pseudo-
genes are depicted by green and red chevrons, respectively.
(C) A five-way alignment of ~5.3 kbp repeat sequences from both haplotypes. Alignment of base positions is shown along the top of
the diagram. Each repeat sequence (three from NA18956 and two from GRCh37) is represented by a single horizontal black line.
Blue tick marks on each line indicate nucleotide (nt) differences and gaps observed between the aligned sequences. The red line tracks
the most similar alignment of the middle NA18956 repeat sequence to the other four sequences. Based on nt similarity, the event
breakpoint is presumed to have occurred within the 373 bp region (red box) in which all aligned sequences share 99.7% sequence
identity (372/373 nt).the nine populations screened with the four IGHV CNV
assays. We assessed LD between these SNPs and alleles at
CNV loci using r2 (Table 4). This analysis revealed that,
in general, the genotyped CNVs were poorly represented
(r2 < 0.8) by commercial arrays in all of the populations
screened. LD was stronger between IGHV CNVs and
SNPs found on the Illumina Omni 1Quad, which was
likely a result of the increased density of SNPs in IGH on
this array (noted previously).16 Furthermore, analogous
to trends observed genome-wide,60 we observed that LD
estimates between IGHV CNVs and array SNPs were lowest
in African populations.538 The American Journal of Human Genetics 92, 530–546, April 4, 2Discussion
The primary motivation of this study was to produce a set
of alternative haplotypes that better represent standing
genetic diversity in the IGH locus, such that these
sequences could aid future investigations of the relation-
ships between IGH germline polymorphisms, antibody
expression and function, and disease susceptibility. To
this aim, we have generated an alternative reference
genome assembly for the IGHV, IGHD, and IGHJ gene clus-
ters from a hydatidiform mole BAC library and analyzed
sequence from 36 fosmid clones from a diverse set of013
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Figure 4. A Hotspot of IGH Structural Polymorphism
Each of the five identified haplotypes harboring diverse CNVs is shown relative to GRCh37. Each haplotype is labeled with a sample
identifier, and the length (kbp) is indicated at the right of each haplotype in parentheses. Two haplotypes in this region were identified
from the individual NA18555 (haplotypes A and B). One to four ~25 kbp segmental duplication sequence blocks (or partial blocks), de-
pending on the haplotype, are depicted by shaded blue bars. Deleted regions identified in five of the haplotypes, including GRCh37, are
indicated by red dotted lines. The positions and names of functional IGHV genes (green boxes) are shown in each haplotype. The partial
haplotype identified in this region from individual NA19240 (AC234301), which overlapped that of NA18555 haplotype A and included
the genes IGHV4-30-2, IGHV3-30-3, IGHV4-30-4, and IGHV3-30-5, is not depicted but was included in the analysis and allowed for the
placement of the NA18502 haplotype (also see Figures S1 and S12–S14).ethnic backgrounds. The CH17 assembly represents the
most complete haplotype upon which IGHV CNVs can
be mapped. From these data, we have analyzed 12 large
CNVs ranging in size from 6.5 kbp to 61.1 kbp (Table 1),
including descriptions of polymorphisms implicated in
human disease, at nucleotide resolution. As a result, we
have characterized 222 kbp of insertion sequence not pres-
ently found in the human reference genome, effectively
increasing the length of available reference sequence in
the IGHV locus by over 20% and providing a resource for
future genotyping and association studies.
Annotations of these sequences allowed for the identifi-
cation of 15 IGHV gene alleles. The fact that we identified
15 previously uncharacterized alleles from a targeted
survey in a relatively small sample of individuals suggests
that additional sampling of IGHV gene allelic variation
will be required, especially in less studied populations.
With the exception of the duplication of IGHV3-43 and
deletion of IGHV3-38, each of the CNVs identified here
included genes previously known or suspected to vary in
copy number; however, these events have not previously
been fully sequenced and characterized at the genomic
level. For example, the presence of the 9.5 kbp insertion
including IGHV7-4-1 had been previously identified by
using restriction fragment length polymorphism (RFLP)The Amanalysis in Japanese and European cohorts,61 but the
complete sequence of this insertion was not known. Prior
to this study, up to 28 IGHV functional or ORF genes were
suspected to vary in copy number, either from 0–1 copies
(n ¼ 19) or 1–2 copies (n ¼ 9) per haploid genome.16
Importantly, 12 of the 19 IGHV genes that vary from 0–1
haploid copies are not represented in the human reference
genome.38 We identified four of these 12 genes in the
CH17 haplotype and an additional six in the fosmid haplo-
types described here. In addition, the pseudogene,
IGHV3-h, which is also not represented in GRCh37 but
has previously been observed in 58% of Danish individ-
uals,62 was identified in CH17. Of the remaining seven
‘‘0–1’’ haploid copy genes, all were included in CNVs
analyzed in this study. We also described CNVs that
included duplications of IGHV genes represented in
GRCh37, including four of the nine IGHV genes that are
suspected to vary from 1–2 haploid copies, as well as
a duplication of IGHV3-43 (IGHV3-43D). In summary, we
have characterized haplotypes involving 22 of the known
28 above mentioned copy-number-variable IGHV genes.
Thus, although our sequencing survey facilitated the char-
acterization of an overwhelming majority of suspected
CNVs in IGHV, our results suggest that, similar to IGHV
coding variation, more work will be necessary to completeerican Journal of Human Genetics 92, 530–546, April 4, 2013 539
Table 3. Allele Frequencies of Genotyped CNVs
Population N Abbreviation Region
V7-4-1
Insertion
V5-a and
V3-64D (CH17)
V4-b, V3-43D, V3-d,
and V1-c Insertion
V1-69, V2-70,
V1-f Insertiona,1
V1-69, V2-70,
V1-f Insertion2
Luyha 48 LWK Africa 0.51 0.15 0.65 0.57 0.41
Maasai 46 MKK Africa 0.42 0.16 0.45 0.42 0.34
Yoruba 48 YRI Africa 0.34 0.03 0.56 0.52 0.45
Han Chinese 45 CHB Asia 0.79 0.20 0.23 0.08 0.04
Japanese 46 JPT Asia 0.78 0.21 0.08 0.02 0.00
Finnish 48 FIN Europe 0.75 0.47 0.13 0.19 0.18
British 48 GBR Europe 0.65 0.48 0.12 0.22 0.16
Iberian 48 IBS Europe 0.54 0.34 0.12 0.16 0.15
Toscani 48 TSI Europe 0.62 0.46 0.14 0.24 0.22
Chimpanzee 5 PTR NA 0.80 0.00 0.80 0.00 NT
Gorilla 5 GGO NA 1.00 0.00 1.00 1.00 NT
Orangutan 5 PPY NA 0.00 1.00 0.40 0.00 NT
aAssuming Hardy-Weinberg equilibrium,1 Standard PCR assay,2 and TaqMan PCR assay. NA, not applicable; NT, not tested.descriptions of CNVs in the region. Importantly, the IGH
haplotypes generated here will provide a starting point
from which additional CNVs can be identified.
In addition to confirming previously reported CNVs in
IGH, our data also allowed for IGHV genes involved in
the same CNV polymorphism to be definitively ordered
into genomic haplotypes, either validating or improving
the characterization of previously suspected variants in-
ferred by PCR, RFLP, or expressed IGHV gene analysis.
For example, a deletion of IGHV3-9 and IGHV1-8 had
been reported in some haplotypes;24,26,27,29 our data
confirmed this but also revealed that rather than these
genes occurring as a simple deletion variant, they were re-
placed by two unrelated genes, IGHV5-a and IGHV3-64D,
not previously known to co-occur on the same haplotype.
It is interesting to note that recent descriptions of putative
IGHV haplotypes based on the analysis of expressed anti-
body repertoires showed that IGHV5-a is present only
on individual haplotypes lacking IGHV1-8 and
IGHV3-9.24,26,27,29 Our genotyping data also support this
finding because all individuals lacking the IGHV1-8 and
IGHV3-9 haplotype were positive for the IGHV5-a and
IGHV3-64D haplotype. Despite the fact that these data,
taken together, support the notion that the IGHV5-a and
IGHV3-64D variant in CH17 is genuine, further sequence
validation of this complex event in additional haplotypes
should be conducted. Similarly, IGHV1-69 and IGHV2-70
have also been suggested to occur as part of the same dupli-
cation, which we confirmed from the CH17 haplotype.
However, our data revealed that this 38 kbp duplication
also included the previously unmapped pseudogene
IGHV3-h 62 and was associated with the presence of
IGHV1-f.
The repetitive nature of the IGHV locus, which is
primarily the result of IGHV gene duplication,20 is540 The American Journal of Human Genetics 92, 530–546, April 4, 2presumed to have facilitated the high frequency of struc-
tural variation found throughout the locus.25 Because
complete descriptions of CNVs in IGHV have remained
limited until now, an assessment of the mutational mech-
anisms directing haplotype diversity across the locus has
not been possible. Our data provide strong evidence that
NAHR appears to be the dominating mechanism under-
lying haplotype diversity in the region. For 10 of the 11
CNVs for which NAHR was suspected, event-mediating
sequences were closely associated with IGHV genes or
pseudogenes, suggesting that the evolutionary expansion
of the IGHV genes and the generation of associated
segmental duplications have provided substrate for the
formation of the majority of CNVs in the locus. Similar
to IGHV, complex and repetitive genomic architectures
are also known to underlie CNVs in the IGHC
locus17–19,21,22,52,53 and in other immune system gene
loci, such as killer immunoglobulin receptor (KIR) genes
and beta-defensins.63–66
Extensive overlap of CNVs with segmental duplications
has been observed in both human and primate
genomes.67,68 In fact, the recent discovery that an increase
in segmental duplications occurred genome-wide in the
ancestor of humans and African great apes implicates
such regions in the formation of shared and species-
specific CNVs.69 We found that four of the CNV-contain-
ing haplotypes characterized in this study (three insertions
and one complex event) were also present in at least one of
three nonhuman primates. Two of the insertions included
large segmental duplications encompassing functional
IGHV genes that mediated the deletions observed in the
human genome reference assembly. Although we did not
observe direct evidence that any of the four loci were poly-
morphic within chimpanzee, gorilla, or orangutan, vari-
ants at two of the loci were observed in only one of the013
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Figure 5. Pairwise Fst of Copy-Number
Variant Loci in Nine Human Populations
Heatmaps representing pairwise Fst values
between populations calculated based on
CNV allele frequency data generated at
four loci are as follows: (A) IGHV7-4-1
insertion; (B) IGHV3-9, IGHV1-8, IGHV5-
a, and IGHV3-64D complex event; (C)
IGHV1-c, IGHV3-d, IGHV3-43D, and
IGHV4-b insertion; and (D) IGHV1-69D,
IGHV1-f, IGHV3-h, and IGHV2-70D inser-
tion. Population abbreviations are shown
on both map axes. Colors in each square
correspond to a given Fst value range as
indicated by the key.three species, suggesting the potential for fixed differences
between species; however, it is important to note that we
screened only a very small number of individuals (n ¼ 5
per species), and thus we cannot rule out effects of limited
sample size or species-specific sequence variability on assay
performance. We found evidence of the insertion haplo-
type that included IGHV1-69D and IGHV2-70D in gorilla,
but not in chimpanzee or orangutan. Specific IGHV1-69
alleles have been shown to be important in neutralizing
antibodies isolated from three human populations against
particular influenza epitopes,70–73 leading to the hypoth-
esis that IGHV1-69 evolved to respond quickly during the
initial stages of infection.73 Furthermore, extensions of
this hypothesis suggest a potential role for infection-driven
B cell clonal expansion in the development of chronic
lymphocytic leukemias [MIM 151400],73 motivated by
the observation that these cancers are often associated
with B cell usage of particular IGHV genes, especially
IGHV1-69.74–76 Interestingly, usage of IGHV1-69 is notThe American Journal of Humacommonly found in individuals with
B cell lymphoma from Asian popula-
tions.76 It is worth noting that inves-
tigations of IGHV1-69 provide the
only example explicitly connecting
IGHV gene copy number to gene
usage,77 which might be important
considering that we found Asians to
have low IGHV1-69 copy number
compared to African and European
populations.
In fact, we observed evidence of
population stratification for all of
the CNVs screened here, because
each locus had pairwise Fst values
above 0.3 for at least two of the popu-
lations surveyed, with some values
reaching upward of 0.5. Population
differences had been noted previously
for one of the CNVs (IGHV7-4-1 inser-
tion61), although this report included
fewer individuals and populations.
However, prior to this study, the re-maining three CNVs had only been screened in individuals
of European descent; thus, our data represent the most
extensive survey of IGHV CNVs to date. Our findings
seem somewhat striking given that we surveyed only
four CNVs but observed differences in population allele
frequencies at each locus. For example, this is in contrast
to a previous examination of Fst at 190 insertion-deletion
loci in three populations, also identified from discordant
fosmid clones, which showed that only 20 of these
polymorphisms exhibited Fst values above 0.35.
3 The
high Fst values observed for the IGHV CNV screened
here might reflect the fact that these particular variants
associate with segmental duplication and include func-
tional genes—two features that have been suspected
to influence selection.14 In addition, population differ-
ences have also been noted for CNVs involving genes
related to the immune response, and in many instances
these genes have been implicated in disease risk and
progression.11,12,78n Genetics 92, 530–546, April 4, 2013 541
Table 4. Commercial Array SNPs in Linkage Disequilibrium with IGHV CNVs
Population Abbreviation Region V7-4-1 Insertion
V5-a, V3-64D, V3-9,
V1-8 Complex Event
V4-b, V3-43D, V3-d,
V1-c Insertion
V1-69, V2-70,
V1-f Insertiona
Luyha LWK Africa 0.28 (rs8005760) 0.30 (rs12586543) 0.29 (rs11847718) 0.36 (rs10129255)
Yoruba YRI Africa 0.09 (rs17646414) 0.34 (rs4774001) 0.10 (rs2337470) 0.13 (rs17112644)
Han Chinese CHB Asia 0.10 (rs885883) 0.17 (rs8010605) 0.37 (rs41471651) 0.63 (rs17113366)
Japanese JPT Asia 0.05 (rs10141701) 0.23 (rs17113281) 0.76 (rs41471651) NA
Finnish FIN Europe 0.21 (rs8005760) 0.21 (rs4774028) 0.19 (rs41471651) 0.49 (rs17672538)
British GBR Europe 0.14 (rs6576127) 0.29 (rs10150642) 0.30 (rs17646414) 0.81 (rs17672538)
Toscani TSI Europe 0.09 (rs4774001) 0.18 (rs17737576) 0.43 (rs17646414) 0.69 (rs17672538)
Affymetrix 6.0 SNP Chip
Population Abbreviation Region V7-4-1 Insertion
V5-a, V3-64D, V3-9,
V1-8 Complex Event
V4-b, V3-43D, V3-d,
V1-c Insertion
V1-69, V2-70,
V1-f Insertiona
Luyha LWK Africa 0.26 (rs17112739) 0.68 (rs2077170) 0.27 (rs12886451) 0.38 (rs6576220)
Yoruba YRI Africa 0.22 (rs12365) 0.34 (rs12588113) 0.40 (rs2027916) 0.27 (rs11848687)
Han Chinese CHB Asia 0.57 (rs7144717) 0.49 (rs2077170) 0.84 (rs7400983) 0.16 (rs4774166)
Japanese JPT Asia 0.55 (rs12884400) 0.72 (rs2077170) 0.76 (rs4774143) NA
Finnish FIN Europe 0.65 (rs1985733) 0.92 (rs2077170) 0.42 (rs2106002) 0.47 (rs10141910)
British GBR Europe 0.67 (rs7144717) 0.81 (rs2077170) 0.37 (rs7146845) 0.71 (rs10141910)
Toscani TSI Europe 0.53 (rs7144717) 0.73 (rs2077170) 0.61 (rs7400983) 0.69 (rs10141910)
Illumina Omni 1 Quad
SNPs with the highest LD values for a given CNV and population are shown; r2 values are indicated for each SNP. NA, not applicable.
aGenotype data used from TaqMan assay.Ultimately, it will be important to understand the role of
IGHV germline CNVs and allelic polymorphisms in
antibody expression and the potential influences of these
variants on human disease. IGHV gene copy number
differences and point mutations in IGHV gene regulatory
sequences are likely to be important factors underlying
individual differences in IGHV gene usage in expressed
antibody repertoires.77,79 This point has recently been
bolstered by observations of strong correlations between
IGHV gene usage in naive antibody repertoires of monozy-
gotic twins, suggesting the involvement of heritable
factors.54 With respect to copy-number variation, we also
observed haplotypes containing deletions of IGHV genes
that have been shown to be absent in expressed naive anti-
body repertoires in some individuals.24,26,27,29,54 The
development of robust genotyping assays provided for by
the sequence presented here will now allow for more direct
connections between IGHV CNVs and gene expression—
an important step toward understanding the potential
roles of these polymorphisms in disease.
To date there have been few human diseases linked to
IGHV polymorphisms. For example, only one putative
association has been reported as part of standard GWAS
(Kawasaki disease [MIM 611775]32), and of the associations
that have been reported from candidate-gene studies, few
have been robustly replicated. We propose that the lack
of GWAS associations might be the result of poor SNP542 The American Journal of Human Genetics 92, 530–546, April 4, 2coverage and fragmented LD in the region, which can
vary depending on ethnicity. Our analysis of four IGHV
CNVs and SNPs from two commercial arrays supports
this, because most of the CNVs were poorly tagged by
surrogate SNPs in the populations surveyed, particularly
those of African descent. For example, only 7% of the
possible CNVs and population intersections showed signif-
icant association with a tag SNP (r2 > 0.8). Similar observa-
tions have also been shown for IGHV gene allelic SNPs.16 It
is also important to note that our LD analysis excluded
CNVs in the IGHV4-28 to IGHV4-34 gene region, in which
we identified five previously uncharacterized CNV-con-
taining haplotypes in addition to GRCh37. Several of these
variants, although unique, included insertions and dele-
tions of the same genes. For example, IGHV4-31 and
IGHV3-30 were deleted in more than one haplotype; like-
wise, duplicates of IGHV3-30 (IGHV3-30-3 and IGHV3-
30-5) were also observed on several haplotypes (Figure 4).
Consistent with previous findings,24,27,55,56 these data
indicate that diploid copy number of IGHV3-30 and
related genes can range from zero to six. Importantly,
genotypes lacking these genes have been associated to
rheumatoid arthritis [MIM 180300], chronic idiopathic
thrombocytopenic purpura [MIM 188030], and systemic
lupus erythematosus [MIM 152700].31,33,57,58 The impor-
tance of this point is that the occurrence of recurrent
CNVs is known to have significant impacts on correlations013
between such variants and neighboring SNPs.80 Thus,
given the presence of recurrent but overlapping events in
this region, it would not be surprising if CNVs involving
IGHV3-30 and other genes between IGHV4-28 and
IGHV4-34 were also poorly represented by neighboring
SNPs and might explain why previous disease associations
in the region have not been replicated using high-
throughput techniques. Such considerations would also
be important for CNVs that include insertions and dele-
tions of functional IGHV genes with known allelic poly-
morphisms, for example, IGHV1-69 and IGHV1-69D for
which at least 12 CNV haplotypes and 14 alleles are
known.56,81 In such instances, it might be essential to
take into account the effects of both types of variation
for studies of disease association.
In summary, we have undertaken the most extensive
genomic sequencing study in the IGH locus to date, from
which we have generated sequence and characterized
a significant portion of ‘‘missing’’ IGHV genes, as well as
an overwhelming majority of IGHV genes previously re-
ported to be involved in structural variation. These data
provide a useful foundation for continued efforts toward
the establishment of a more complete genomic map of
this complex region of the genome. The sequence gener-
ated here will also undoubtedly aid the development of
more effective genomic tools in the IGH locus, which
will be essential for exploring the evolutionary history of
IGH genes and their diversity in human populations, and
will ultimately provide a stronger framework for under-
standing the potential role of IGH genetic diversity in anti-
body expression and human disease. In a broader context,
our findings can also serve as an illustrative example for
those studying other structurally complex regions of the
genome for which genomic reference sequence data
remain limited. The CH17 BAC resource, for example,
has already been used to discover and describe missing
sequence including previously uncharacterized genes.34
Many other stretches of highly homologous sequence are
now being identified as a result of this haploid resource.
In addition, for loci that are somatically rearranged,
including immunoglobulin and T cell receptor loci, the
germline nature of this clone resource allows for the char-
acterization of a single haplotype unaffected by somatic re-
arrangement.Supplemental Data
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